Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling access to accelerated and rolling review FDA clearance of IND application enables initiation of…
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Press release – No. 7 / 2026 Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston…
Nxera Pharma's QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera's partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026 QUVIVIQ is approved through Taiwan's Streamlined Review Designation pathway…
India moving up the pharma value chain
In the global pharmaceutical landscape, biologics, biosimilars and specialty drugs now account for over 40 per cent of pharmaceutical revenues. Long termed as the ‘Pharmacy of the World' due to its leadership in generic medicines, India's…
BridgeBio Pharma (NASDAQ:BBIO) CEO Sells $2,984,800.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 40,000 shares of BridgeBio Pharma stock in a transaction dated Thursday, April 9th. The shares were sold at an average price of $74.62, for a total value of $2,984,800.00.
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Update
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 1,470 shares, an increase of 54.6%…
Robeco Institutional Asset Management B.V. Decreases Holdings in Royalty Pharma PLC $RPRX
Robeco Institutional Asset Management B.V. trimmed its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 24.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Should You Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $25.33, but opened at $26.36. Ascentage Pharma Group International shares last…
Aravax appoints
Specialist Media Pty Ltd ACN 666 958 783 and its related entities (Specialist Media) collects, uses, and discloses the Personal Information provided by you in this form to review and respond to your submission and for the purposes set out in our…
Cough drops sold nationwide recalled over undisclosed 'quality issues
READ MORE: More than 350,000 vitamins and supplements recalled More than a dozen types of cough drops have been urgently recalled due to undisclosed 'quality issues.' China-based firm Xiamen Kang Zhongyuan Biotechnology Co., Ltd., voluntarily…
Post-communist Cuba will need an export-led recovery
The slow-motion implosion of the Cuban economy is accelerating. While Venezuela has provided Cuba with heavily subsidized (practically free) oil, the removal of Nicolas Maduro as president combined with Russia's reluctance to contribute substantial…
Is the Nifty Party Over? Goldman Sachs Cuts Year-End Target by 14% as $100 Oil Hits Earnings
The revision comes as Goldman Sachs cut its 2026 earnings growth forecast for India from 16% to just 8%. While the recent surge in crude oil to over $100 per barrel acted as a catalyst, market analysts suggest the 'India story' was already under…
Helical raises $10M to bridge the gap between foundation models and drug discovery decisions
Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows.
Swiss continues to suspend flights to Dubai
Inside Geneva: can the UN survive? Read more: Inside Geneva: can the UN survive? Switzerland's Zug becomes bolt-hole for Gulf-based wealth Read more: Switzerland's Zug becomes bolt-hole for Gulf-based wealth Swiss entrepreneurs are staying put in…
Patient Capital Management Q1 2026 Portfolio Activity & Attribution
During the first quarter of 2026, the Patient Opportunity Equity Strategy generated a total return of -5.96% net of fees. In comparison, the Strategy's unmanaged benchmark, the S&P 500 Index (SPX), returned -4.33%.Using a three-factor performance…
Receive a Daily briefing on Pharma Industry News
Get Started